A 48-Week Study of Fat Molecular Alterations in HIV Naive Patients Starting Tenofovir/Emtricitabine With Lopinavir/Ritonavir or Efavirenz-Reference-Cited by-同舟云学术

A 48-Week Study of Fat Molecular Alterations in HIV Naive Patients Starting Tenofovir/Emtricitabine With Lopinavir/Ritonavir or Efavirenz

Published:2014-08-15 Issue:5 Volume:66 Page:457-465
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Domingo Pere,Gutierrez Maria del Mar,Gallego-Escuredo José Miguel,Torres Ferran,Mateo Maria Gracia,Villarroya Joan,Lamarca Karuna,Domingo Joan Carles,Vidal Francesc,Villarroya Francesc,Giralt Marta

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference35 articles.

1. . Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.;Domingo;AIDS Rev,2012

2. Lipodystrophy associated with highly active antiretroviral therapy for HIV infection: the adipocyte as a target of antiretroviral-induced mitochondrial toxicity.;Giralt;Trends Pharmacol Sci,2005

3. ; Prometheus study group. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.;van der Valk;AIDS,2001

4. . Metabolic outcomes in a randomized trial of nucleoside, non-nucleoside and protease inhibitor-sparing regimens for initial HIV treatment.;Haubrich;AIDS,2009

5. 1993 revised classification system for HIV infection and expanded surveillance for case definition for AIDS among adolescents and adults.;MMWR,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy;Journal of Clinical Medicine;2022-01-22

2. HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation;Journal of the American Heart Association;2020-10-06

3. Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV;Journal of Pediatric Gastroenterology & Nutrition;2020-08-14

4. Potential role of the melanocortin signaling system interference in the excess weight gain associated to some antiretroviral drugs in people living with HIV;International Journal of Obesity;2020-02-20

5. Does choice of antiretroviral drugs matter for inflammation?;Expert Review of Clinical Pharmacology;2019-04-24